Mr Stchur joined Asterand in 2002 and led the company through two rounds of venture funding and listing on the London Stock Exchange by means of a reverse merger (with Pharmagene) to form Asterand in January 2006. He was appointed CFO and corporate secretary of the new group in 2007.
Jack Davis, chairman of Asterand, said: “I’m pleased to welcome John to the board. His leadership and exceptional management of the company’s finances have been key factors in our growth.
“John is a talented business leader with extensive knowledge of Asterand’s markets and operations. I am confident that John’s contribution will be invaluable as we continue to pursue our strategic objectives of sustained profitability and future growth.”